Innovation Theater Breakfast: Double Down on Integral Debridement: Two Revolutionary Modalities in Advancing Wound Compression

Recent consensus guidelines published in the Journal of Wound Care on Best Practices in Debridement 2024 highlight that wounds today often require more than one debridement method. This evolving approach, known as Integral Debridement, involves the strategic use of complementary debridement modalities on the same wound to deliver a more tailored, patient-centric approach to care. Integral Debridement not only personalizes treatment but also helps overcome limitations in scope of practice across care settings. The guidelines emphasize two critical challenges in wound care: the rapid reformation of microbial biofilms and slough—often within 24 hours post-debridement—and the need to enhance debridement efficacy with amplifiers such as pure hypochlorous acid, a wound cleanser offering an optimal therapeutic index to support healing. This concept of therapeutic index was formally included in the list of considerations for therapeutic wound cleansing in the 2025 IWII Therapeutic Wound Cleansing Consensus Guidelines. Join this expert panel as they explore how therapeutic wound cleansing, therapeutic index, and continuous debridement form the foundation of the Integral Debridement approach. The discussion will spotlight the synergistic role of UrgoClean Ag, with its proprietary charged fibers that continuously cleanse the wound bed throughout wear time, and Vashe, which supports debridement and sustains the therapeutic environment needed for healing. When used together, these concepts and technologies form a cohesive, evidence-based strategy—each enhancing the other’s impact. UrgoClean Ag and Vashe are stronger together, reinforcing the principles of Integral Debridement and delivering improved wound outcomes across multiple care settings.

Sponsor: Urgo Medical North America